129 related articles for article (PubMed ID: 11274756)
1. Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA.
Payen E; Bettan M; Rouyer-Fessard P; Beuzard Y; Scherman D
Exp Hematol; 2001 Mar; 29(3):295-300. PubMed ID: 11274756
[TBL] [Abstract][Full Text] [Related]
2. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia.
Villeval JL; Rouyer-Fessard P; Blumenfeld N; Henri A; Vainchenker W; Beuzard Y
Blood; 1994 Aug; 84(3):928-33. PubMed ID: 8043875
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer.
Kreiss P; Bettan M; Crouzet J; Scherman D
J Gene Med; 1999; 1(4):245-50. PubMed ID: 10738557
[TBL] [Abstract][Full Text] [Related]
5. Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo.
Dalle B; Henri A; Rouyer-Fessard P; Bettan M; Scherman D; Beuzard Y; Payen E
Blood; 2001 Jun; 97(12):3776-82. PubMed ID: 11389016
[TBL] [Abstract][Full Text] [Related]
6. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
[TBL] [Abstract][Full Text] [Related]
7. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles.
Samakoglu S; Bohl D; Heard JM
Mol Ther; 2002 Dec; 6(6):793-803. PubMed ID: 12498775
[TBL] [Abstract][Full Text] [Related]
9. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
[TBL] [Abstract][Full Text] [Related]
10. Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation.
Terada Y; Tanaka H; Okado T; Shimamura H; Inoshita S; Kuwahara M; Akiba T; Sasaki S
Kidney Int; 2002 Dec; 62(6):1966-76. PubMed ID: 12427121
[TBL] [Abstract][Full Text] [Related]
11. Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model.
Johnston J; Tazelaar J; Rivera VM; Clackson T; Gao GP; Wilson JM
Mol Ther; 2003 Apr; 7(4):493-7. PubMed ID: 12727112
[TBL] [Abstract][Full Text] [Related]
12. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure.
Rizzuto G; Cappelletti M; Mennuni C; Wiznerowicz M; DeMartis A; Maione D; Ciliberto G; La Monica N; Fattori E
Hum Gene Ther; 2000 Sep; 11(13):1891-900. PubMed ID: 10986561
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
[TBL] [Abstract][Full Text] [Related]
14. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
15. Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
Sun J; Wang Y; Yang J; Du D; Li Z; Wei J; Yang A
Exp Mol Med; 2012 Nov; 44(11):674-83. PubMed ID: 22990115
[TBL] [Abstract][Full Text] [Related]
16. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.
Tripathy SK; Svensson EC; Black HB; Goldwasser E; Margalith M; Hobart PM; Leiden JM
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10876-80. PubMed ID: 8855275
[TBL] [Abstract][Full Text] [Related]
17. Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells.
Moi P; Sadelain M
Haematologica; 2008 Mar; 93(3):325-30. PubMed ID: 18310536
[No Abstract] [Full Text] [Related]
18. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation.
Maruyama H; Sugawa M; Moriguchi Y; Imazeki I; Ishikawa Y; Ataka K; Hasegawa S; Ito Y; Higuchi N; Kazama JJ; Gejyo F; Miyazaki JI
Hum Gene Ther; 2000 Feb; 11(3):429-37. PubMed ID: 10697117
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice.
Gothelf A; Hojman P; Gehl J
Gene Ther; 2010 Sep; 17(9):1077-84. PubMed ID: 20410932
[TBL] [Abstract][Full Text] [Related]
20. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.
Rizzuto G; Cappelletti M; Maione D; Savino R; Lazzaro D; Costa P; Mathiesen I; Cortese R; Ciliberto G; Laufer R; La Monica N; Fattori E
Proc Natl Acad Sci U S A; 1999 May; 96(11):6417-22. PubMed ID: 10339602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
